BOSTON and LONDON — November 7, 2025 — Leads & Copy — Centessa Pharmaceuticals plc (Nasdaq: CNTA) will participate in several upcoming investor conferences, the company announced today.
Management team members will be featured at the following events:
Guggenheim 2nd Annual Healthcare Innovation Conference
Date: Wednesday, November 12, 2025
Fireside Chat: 10:30 AM ET
Jefferies Global Healthcare Conference in London
Date: Tuesday, November 18, 2025
Fireside Chat: 2:00 PM GMT/ 9:00 AM ET
37th Annual Piper Sandler Healthcare Conference
Date: Tuesday, December 2, 2025
Fireside Chat: 3:00 PM ET
8th Annual Evercore Healthcare Conference
Date: Wednesday, December 3, 2025
Fireside Chat: 9:35 AM ET
Oppenheimer Movers in Rare Disease Summit
Date: Thursday, December 11, 2025
Live webcasts and archived recordings of these events will be accessible in the “Events and Publications” section of Centessa Pharmaceuticals’ investor relations website.
Centessa Pharmaceuticals, plc is a clinical-stage company focused on discovering, developing, and delivering medicines that are transformational for patients. The company is pioneering a new class of potential therapies within its orexin receptor 2 (OX2R) agonist program for the treatment of excessive daytime sleepiness (EDS), impaired attention, cognitive deficits, fatigue, and other symptoms across neurological, neurodegenerative, and neuropsychiatric disorders.
Kristen K. Sheppard, Esq., SVP of Investor Relations, can be reached at investors@centessa.com.
Source: Centessa Pharmaceuticals
